Best supplements for migraines: Four vitamins and minerals to take instead of painkillers

BEST supplements for migraines: Migraines are disabling headaches characterised by one sided pulsating pain. There ’s currently no cure, but a range of treatments available to help ease the symptoms. Certain vitamins and minerals offer a natural remedy, according to experts.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news

Related Links:

AbstractHeadache is a milestone in cerebrovascular disorders; indeed, it may represent the only symptom at onset or predominates over the other neurological features. Unfortunately, headache associated with cerebrovascular diseases lacks clear-cut characteristics as it may resemble a migraine attack, tension-type headache, or cluster headache; pain localization is also misleading along with drug (analgesic) response. However, in this review, we have analyzed and described the most common patterns of headache for different vascular disorders: it is known that headache due to subarachnoid aneurysmal hemorrhage presents pecul...
Source: Neurological Sciences - Category: Neurology Source Type: research
Death By 1,000 Clicks: Where Electronic Health Records Went WrongFred Schulte, Kaiser Health News and Erika Fry, Fortune The pain radiated from the top of Annette Monachelli ’s head, and it got worse when she changed positions. It didn’t feel like her usual migraine. The 47-year-old Vermont attorney turned innkeeper visited her local doctor at the Stowe Family Practice twice about the problem in late November 2012, but got little relief. Two months later, Monachelli was dead of a brain aneurysm, a condition that, despite the symptoms and the appointments, had never been tested for or diagnosed until she turned...
Source: Australian Health Information Technology - Category: Information Technology Authors: Source Type: blogs
Theranica Bio-Electronics said yesterday that it raised a $35 million Series B round for the Nerivio Migra neurostim patch it’s developing to treat migraine headache. Netanya, Israel-based Theranica said VC shop aMoon led the round, joined by all of its existing backers, Lightspeed Venture Partners, LionBird, Corundum Open Innovation and Takoa. The company raised an unspecified amount in its seed round back in September 2016. Theranica closed out a nearly 300-patient pivotal study last October it used to back a bid for FDA clearance that met its primary endpoint and showed “high efficacy, safety and tolerabilit...
Source: Mass Device - Category: Medical Devices Authors: Tags: Featured Funding Roundup Neuromodulation/Neurostimulation Pain Management Wall Street Beat Theranica Bio-Electronics Source Type: news
No abstract available
Source: Topics in Pain Management - Category: Anesthesiology Tags: CONTINUING EDUCATION ACTIVITY Source Type: research
This article reviews the anatomy, clinical features, unique diagnostic considerations, and management approaches relating to ON and CGH.Recent FindingsConservative therapeutic approaches are considered first-line. Anesthetic nerve blocks may have a dual role in both supporting diagnosis and providing pain relief. Newer minimally invasive procedures, such as pulsed radiofrequency (PRF) and occipital nerve stimulation (ONS), represent an exciting therapeutic avenue for severe/refractory cases. Surgical interventions should be reserved for select patient populations who have failed all other conservative and minimally invasiv...
Source: Current Neurology and Neuroscience Reports - Category: Neuroscience Source Type: research
AbstractPurpose of ReviewNew daily persistent headache (NDPH) is a rare primary headache disorder, which often has a refractory clinical course. This narrative review seeks to highlight what is known about the development of NDPH, to outline a diagnostic approach to a patient with new daily headache, and to explore management considerations and potential future therapies for patients diagnosed with NDPH.Recent FindingsInterval work at the level of case series and cohort studies has identified novel triggering factors (e.g., Valsalva), subgroups with unique temporal profiles (e.g., thunderclap onset), psychophysical profile...
Source: Current Neurology and Neuroscience Reports - Category: Neuroscience Source Type: research
AbstractPurpose of ReviewWith an aging population and increased prevalence of the disease, we set out to evaluate the validity of current diagnostic criteria for neurogenic claudication as well as the efficacy of the treatment options for the main cause, lumbar spinal stenosis (LSS).Recent FindingsEpidural steroid injections (ESI) were most efficacious when the injectate is a steroid combined with lidocaine or lidocaine only. There are promising results regarding the efficacy of the minimally invasive lumbar decompression (MILD) procedure as well as interspinous process spacers (IPS) compared to surgical alternatives. Spin...
Source: Current Pain and Headache Reports - Category: Neurology Source Type: research
Conditions:   Migraine;   Pain;   Nausea;   Vomiting;   Aura Interventions:   Drug: Arm 1: CL-H1T;   Drug: Arm 2: CL-H1T;   Drug: Arm 3: Sumatriptan Succinate 100 mg capsule;   Drug: Arm 4: Promethazine HCl 18.75 mg;   Drug: Arm 5: Promethazine HCl 37.5 mg;   Other: Placebo Sponsor:   Charleston Laboratories, Inc Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
PMID: 30883724 [PubMed - as supplied by publisher]
Source: Headache - Category: Neurology Authors: Tags: Headache Source Type: research
AbstractPurpose of ReviewThe purpose of this review is to summarize the current understanding of opioid pathways in mediating and/or modulating analgesia and adverse effects. Oliceridine is highlighted as a novel mu-opioid receptor agonist with selective activation of G protein and β-arrestin signaling pathways.Recent FindingsOliceridine (TRV130; [(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl]ethyl})amine) is a novel MOR agonist that selectively activates G protein and β-arrestin signaling pathways. A growing body of evidence suggests that compared to existing MOR agonists, O...
Source: Current Pain and Headache Reports - Category: Neurology Source Type: research
More News: Headache | Health | Migraine | Minerals | Pain | Vitamins